Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP926502.RA6RISl19-4JmuqEj4KKK9Z8yDLe5WWrat-JXP5YujrwU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP926502.RA6RISl19-4JmuqEj4KKK9Z8yDLe5WWrat-JXP5YujrwU130_assertion type Assertion NP926502.RA6RISl19-4JmuqEj4KKK9Z8yDLe5WWrat-JXP5YujrwU130_head.
- NP926502.RA6RISl19-4JmuqEj4KKK9Z8yDLe5WWrat-JXP5YujrwU130_assertion description "[To evaluate whether p21 (WAF-1/CIP1) should be considered a potential candidate for human bladder cancer gene therapy, we determined: (1) the basal level of p21 expression in bladder cancer cell lines, (2) the response of bladder cancer cells to increased p21 expression following p21 adenovirus infection, and (3) the mechanism of growth inhibition produced by p21 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926502.RA6RISl19-4JmuqEj4KKK9Z8yDLe5WWrat-JXP5YujrwU130_provenance.
- NP926502.RA6RISl19-4JmuqEj4KKK9Z8yDLe5WWrat-JXP5YujrwU130_assertion evidence source_evidence_literature NP926502.RA6RISl19-4JmuqEj4KKK9Z8yDLe5WWrat-JXP5YujrwU130_provenance.
- NP926502.RA6RISl19-4JmuqEj4KKK9Z8yDLe5WWrat-JXP5YujrwU130_assertion SIO_000772 10688044 NP926502.RA6RISl19-4JmuqEj4KKK9Z8yDLe5WWrat-JXP5YujrwU130_provenance.
- NP926502.RA6RISl19-4JmuqEj4KKK9Z8yDLe5WWrat-JXP5YujrwU130_assertion wasDerivedFrom befree-20150227 NP926502.RA6RISl19-4JmuqEj4KKK9Z8yDLe5WWrat-JXP5YujrwU130_provenance.
- NP926502.RA6RISl19-4JmuqEj4KKK9Z8yDLe5WWrat-JXP5YujrwU130_assertion wasGeneratedBy ECO_0000203 NP926502.RA6RISl19-4JmuqEj4KKK9Z8yDLe5WWrat-JXP5YujrwU130_provenance.